Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Feb-24 7:48 PM View:  | Helix Acquisition Corp. II (HLXB) | 13-Feb-24 | Grant Duplicate | 509,000 | $10.00 | $5,090,000.00 | 100% 0 to 509.0K | |
| 13-Feb-24 7:48 PM View: | Helix Acquisition Corp. II (HLXB) | 13-Feb-24 | Purchase | 2,400,000 | $10.00 | $24,000,000.00 | 472% 509.0K to 2.91M | |
| 10-Oct-23 4:00 PM View: | Moonlake Immunotherapeutics (MLTX) | 05-Oct-23 | Purchase | 58,839 | $59.90 | $3,524,300.00 | < 1% 8.44M to 8.49M | |
| 04-Oct-23 5:52 PM View: | Moonlake Immunotherapeutics (MLTX) | 04-Oct-23 | Purchase | 67,814 | $57.32 | $3,887,020.00 | < 1% 24.95M to 25.02M | |
| 04-Oct-23 5:52 PM View: | Moonlake Immunotherapeutics (MLTX) | 03-Oct-23 | Purchase | 150,487 | $57.25 | $8,615,680.00 | < 1% 24.8M to 24.95M | |
| 04-Oct-23 5:52 PM View: | Moonlake Immunotherapeutics (MLTX) | 02-Oct-23 | Purchase | 74,911 | $57.37 | $4,297,640.00 | < 1% 24.73M to 24.8M | |
| 05-Jul-23 4:05 PM View: | Moonlake Immunotherapeutics (MLTX) | 30-Jun-23 | Purchase | 800,000 | $50.00 | $40,000,000.00 | 10% 7.8M to 8.6M | |
| 28-Jun-23 6:28 PM View: | Moonlake Immunotherapeutics (MLTX) | 26-Jun-23 | Purchase | 450,000 | $45.63 | $20,535,000.00 | 6% 7.35M to 7.8M | |
| 03-Apr-23 4:30 PM View: | Biomea Fusion, Inc. (BMEA) | 30-Mar-23 | Purchase | 400,000 | $30.00 | $12,000,000.00 | 13% 3.17M to 3.57M | |
| 22-Mar-23 5:07 PM View: | Moonlake Immunotherapeutics (MLTX) | 21-Mar-23 | Purchase | 238,511 | $21.70 | $5,176,000.00 | 4% 6.65M to 6.89M | |
| 22-Mar-23 5:07 PM View: | Moonlake Immunotherapeutics (MLTX) | 20-Mar-23 | Purchase | 588,589 | $19.71 | $11,598,800.00 | 10% 6.07M to 6.65M | |
| 20-Dec-22 5:42 PM View: | Erasca, Inc. (ERAS) | 13-Dec-22 | Private Purchase | 307,692 | $6.50 | $2,000,000.00 | 3% 10.51M to 10.81M | |
| 07-Apr-22 6:26 PM View: | Moonlake Immunotherapeutics (MLTX) | 05-Apr-22 | Conversion Duplicate | 2,785,000 | -- | -- | 648% 430.0K to 3.21M | |
| 07-Apr-22 6:26 PM View: | Moonlake Immunotherapeutics (MLTX) | 05-Apr-22 | Purchase | 2,850,000 | $10.00 | $28,500,000.00 | 89% 3.21M to 6.07M | |
| 10-Aug-21 4:02 PM View: | Erasca, Inc. (ERAS) | 10-Aug-21 | Market Purchase | 200,000 | $22.10 | $4,420,000.00 | < 1% 20.61M to 20.81M | (4%) |
| 10-Aug-21 4:02 PM View: | Erasca, Inc. (ERAS) | 26-Jul-21 | Market Sale | 200,000 | $18.76 | $3,753,000.00 | (< 1%) 20.81M to 20.61M | (13%) |
| 22-Jul-21 4:10 PM View: | Erasca, Inc. (ERAS) | 20-Jul-21 | Conversion | 9,555,550 | -- | -- | 100% 9.56M to 19.11M | |
| 22-Jul-21 4:10 PM View: | Erasca, Inc. (ERAS) | 20-Jul-21 | Private Purchase | 950,000 | $16.00 | $15,200,000.00 | 5% 19.11M to 20.06M | |
| 22-Apr-21 4:09 PM View: | Biomea Fusion, Inc. (BMEA) | 20-Apr-21 | Conversion | 2,270,870 | -- | -- | 100% 2.27M to 4.54M | |
| 22-Apr-21 4:09 PM View: | Biomea Fusion, Inc. (BMEA) | 20-Apr-21 | Purchase | 900,000 | $17.00 | $15,300,000.00 | 20% 4.54M to 5.44M | |
| 22-Oct-20 5:10 PM View: | Moonlake Immunotherapeutics (MLTX) | 22-Oct-20 | Purchase Duplicate | 430,000 | $10.00 | $4,300,000.00 | 100% 0 to 430.0K |